Masahiko Ogihara

981 citations
64 papers · 740 indexed · h-index 16
Topics
Liver physiology and pathology (25 papers)Pancreatic function and diabetes (8 papers)Drug Transport and Resistance Mechanisms (7 papers)
Partner nations
JapanUnited States

In The Last Decade

Masahiko Ogihara

63 papers receiving 717 citations

Peers

Masahiko Ogihara
Comparison fields: 5 of 100
  • Molecular Biology 233
  • Hepatology 197
  • Pharmacology 135
  • Surgery 128
  • Epidemiology 91
Replace Mohamed A. Shaheen with:
Mohamed A. Shaheen Egypt
Jae Kwang Kim South Korea
Lulu Wang China
Qing Wu China
Satish K. Mandlik India
Shaoqi Yang China
Ryohei Hayashi Japan
Raluca Costache Romania
Shengnan Li China
Masahiko Ogihara relative to Mohamed A. Shaheen Egypt Mohamed A. Shaheen's profile →
Citations per field
00.5×4.8×
Mohamed A. Shaheen · 1×
Citations per year

Countries citing papers authored by Masahiko Ogihara

Since Specialization
Citations

This map shows the geographic impact of Masahiko Ogihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiko Ogihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiko Ogihara more than expected).

Fields of papers citing papers by Masahiko Ogihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiko Ogihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiko Ogihara. The network helps show where Masahiko Ogihara may publish in the future.

Co-authorship network of co-authors of Masahiko Ogihara

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiko Ogihara. A scholar is included among the top collaborators of Masahiko Ogihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiko Ogihara. Masahiko Ogihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 26
2 2
3 2
4 7
5 27
6 9
7 19
8 17
9 13
10 10
11 14
12 40
13 8
14 50
15 30
16 42
17 1
18 13
19 2
20 1

About Masahiko Ogihara

Masahiko Ogihara is a scholar working on Hepatology, Pharmaceutical Science and Pharmacology, having authored 64 papers that have together received 740 indexed citations. Recurring topics across this work include Liver physiology and pathology (25 papers), Pancreatic function and diabetes (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Hepatology (197 citations), Pharmacology (135 citations) and Pharmaceutical Science (79 citations). Masahiko Ogihara has collaborated with scholars based in Japan and United States. Frequent co-authors include Mitsutoshi Kimura, Hideshi Natsume, Yasunori Morimoto, Hideo UEDA, Hideo Inoue, Hiroshi Okamoto, Kenji Sugibayashi, Kazuhiro Hirabayashi, Kazuo Ohtake and Katsuyoshi Sunaga. Their work appears in journals such as Analytical Biochemistry, Endocrinology and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026